Appendix 4D 31 December 2025
Filed with ASX · · 3 pages · English
Earlier from EchoIQ
- Quarterly Activities Report and Appendix 4C Cash Flow Report
- Response to ASX Price Query
- Formal lodgement of FDA submission for EchoSolv HF
- Echo IQ to Present at the Life Sciences Virtual Investor Forum on 11th December
- Validation study for EchoSolv HF completed at the Mayo Clinic – Study delivers exceptional results
Later from EchoIQ
- S&P DJI Announces March 2026 Quarterly Rebalance
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- Agreement with Mayo Clinic for EchoSolv HF
- EchoSolv AS deployed into Mount Sinai Health System
- QuarterlyActivities Report and Appendix 4C Cash Flow Report
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ